Freshfields Bruckhaus Deringer and Maples Group are advising AstraZeneca on the transaction, and Cooley and Harney Westwood & Riegels are advising Gracell Biotechnologies. AstraZeneca announced it...
AstraZeneca’s $1.2 Billion Acquisition of Gracell Biotechnologies
Gracell Biotechnologies’ $150 Million Private Placement Financing
Cooley advised Gracell Biotechnologies; and Davis Polk & Wardwell advised the placement agents on the deal. Gracell Biotechnologies Inc. (Nasdaq: GRCL) announced that it has entered into a...